Everyday Chemist

#DisabilityAwareness

Health

Self-Reported Cognitive Disability Rates Increased in U.S. Adults From 2013 to 2023

Cognitive Disability – Over the past decade, the prevalence of self-reported cognitive disability among U.S. adults has risen markedly, highlighting a potentially growing public health concern. A recent study published in Neurology examined data from the Centers for Disease Control and Prevention’s Behavioral Risk Factor Surveillance System (BRFSS) spanning 2013 to 2023 (excluding 2020) and found that cognitive disability

Experimental Drug

Experimental Drug Found to Slow Progression of MS-Related Disability

A new experimental drug is showing promise in slowing the progression of disability in individuals with multiple sclerosis (MS), according to recent findings from a large clinical trial. The results have sparked optimism among patients, neurologists, and researchers alike, as current treatment options for MS often focus primarily on managing symptoms rather than significantly altering the course of the disease.

Scroll to Top